Synthesis of novel CCR1 antagonists for treatment of glioblastoma

被引：0

作者：

Faizal, Fathima A. ^{[1
]}

Mack, Kyeara ^{[1
]}

Shepherd, Ethan ^{[1
]}

Chakravorti, Shoumyo ^{[1
]}

Gill, Molly ^{[1
]}

Notarmaso, Michael ^{[1
]}

Pabon, Isabella ^{[1
]}

Patel, Neelam ^{[1
]}

Rao, Hamza ^{[1
]}

Yarfi, Joe-Louis ^{[1
]}

Xie, Joy ^{[1
]}

Merritt, James ^{[1
]}

机构：

[1] Kean Univ, NJCSTEM, Edison, NJ USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2018年 / 255卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

页数：1

共 50 条

[31] Identification of highly specific nonpeptide antagonists of the CCR1 receptor.
Horuk, R
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U62 - U62
[32] MEDI 207-Discovery of novel, orally available piperidine-containing CCR1 antagonists
Lu, Shou-Fu
Chou, Yuo-Ling
Lee, Wheeseong
Liang, Xiaolin
Phillips, Gary B.
Schlyer, Sabine
Wei, Robert G.
Xu, Jinlou
Yu, Hongyi
Ge, Xue Snow
Harirchian, Paymann
Ribeiro, Sofia
Subramanyam, Babu
Walters, Janette
Horuk, Richard
Kochanny, Monica J.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232
[33] The chemokine receptor CCR1 is involved in microglia stimulated glioblastoma invasion
Coniglio, Salvatore J.
Ramasundaram, Poornema
Fournier, Neshama
Hamilton, Danielle S.
Marshall, Gregory
Smith, Keia
Habib, Diana
Merritt, James R.
CANCER RESEARCH, 2019, 79 (13)
[34] Design, synthesis and structure-activity relationships of zwitterionic spirocyclic compounds as potent CCR1 antagonists
Hossain, Nafizal
Ivanova, Svetlana
Timen, Asa Sjoholm
Bergare, Jonas
Mussie, Tesfaledet
Bergstrom, Lena
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (14) : 4026 - 4030
[35] Automated parallel solid-phase synthesis of non-peptide CCR1 receptor antagonists
Buckman, BO
Ghannam, A
Li, A
Liang, M
Mohan, R
Ng, HP
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2002, 5 (03) : 249 - 251
[36] CCL5, CCR1 and CCR5 in murine glioblastoma: Immune cell infiltration and survival rates are not dependent on individual expression of either CCR1 or CCR5
Kien Pham
Luo, Defang
Liu, Che
Harrison, Jeffrey K.
JOURNAL OF NEUROIMMUNOLOGY, 2012, 246 (1-2) : 10 - 17
[37] Assessing CCR1 Antagonists for Chemotaxis Inhibition in a Multiple Myeloma In Vitro Model
Echeverria, S. L.
Gilchrist, A.
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2021, 57 (SUPPL 1) : S32 - S32
[38] Assessing CCR1 Antagonists for Chemotaxis Inhibition in a Multiple Myeloma in vitro Model
Echeverria, Stephanie
Gilchrist, Annette
FASEB JOURNAL, 2021, 35
[39] Identification and characterization of small molecule functional antagonists of the CCR1 chemokine receptor
Hesselgesser, J
Ng, HP
Liang, M
Zheng, W
May, K
Bauman, JG
Monahan, S
Islam, I
Wei, GP
Ghannam, A
Taub, DD
Rosser, M
Snider, RM
Morrissey, MM
Perez, HD
Horuk, R
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (25) : 15687 - 15692
[40] CCR1 Antagonists: What Have We Learned From Clinical Trials
Gladue, Ronald P.
Brown, Matthew F.
Zwillich, Samuel H.
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2010, 10 (13) : 1268 - 1277

← 1 2 3 4 5 →